Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study.

Englisch, Susanne

Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. [electronic resource] - Journal of clinical psychopharmacology Dec 2016 - 597-607 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article

1533-712X

10.1097/JCP.0000000000000587 doi


Acetamides--administration & dosage
Adult
Antidepressive Agents--administration & dosage
Antipsychotic Agents--therapeutic use
Comorbidity
Depressive Disorder, Major--drug therapy
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Outcome Assessment, Health Care
Prospective Studies
Schizophrenia--drug therapy